HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Belinostat approved for use in treating rare lymphoma.

AuthorsCheryl A Thompson
JournalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (Am J Health Syst Pharm) Vol. 71 Issue 16 Pg. 1328 (Aug 15 2014) ISSN: 1535-2900 [Electronic] England
PMID25074945 (Publication Type: News)
Chemical References
  • Hydroxamic Acids
  • Sulfonamides
  • belinostat
Topics
  • Drug Approval
  • Humans
  • Hydroxamic Acids (adverse effects, therapeutic use)
  • Lymphoma, T-Cell, Peripheral (drug therapy)
  • Sulfonamides (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: